• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

c.slaney@unimelb.edu.au

Credentials


Position
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
Education
Doctoral Degree (Research) / PhD
Victoria University of Wellington
ORCID

0000-0002-6986-6115

Dr Clare Slaney

Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology

72 Scholarly works
15 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Parallel processing of T cells and natural killer cells to enhance in vivo CAR T cell activity against blood and solid cancers
    DOI: 10.1002/cti2.70120
  • 2026

    Journal article

    Rewiring immunity with in vivo CAR T cell engineering
    DOI: 10.1038/s43018-026-01216-0
  • 2026

    Journal article

    Ironing out a metabolic barrier to durable CAR T cell therapy
    DOI: 10.1038/s41422-026-01282-0
  • 2025

    Journal article

    Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models
    DOI: 10.1126/scitranslmed.adk0627
  • 2025

    Research grants (other domestic)

    Rejuvenating the Lymph Nodes to Treat Breast Cancer Metastasis
  • 2022

    Research grants (other domestic)

    mRNA BEATs Technology to Enhance CAR T Cell Therapy of Cancer
  • 2022

    Research grants (other domestic)

    mRNA BEATs Technology to Enhance CAR T Cell Therapy of Cancer
Clare Slaney

Latest Honours,
Awards and Fellowships


2023
VCA mid career fellowship
2021
NHMRC Fellowship (NHMRCF)
2018
Mavis Robertson Award National Breast Cancer Foundation
2016
NBCF career development fellowship

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Optimised modular anti-FLAG CAR T cells for solid tumor therapy
    DOI: 10.1002/cti2.70046
  • 2024

    Journal article

    Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals
    DOI: 10.1002/cti2.70016
  • 2024

    Journal article

    FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
    DOI: 10.1038/s41586-024-07242-1
  • 2023

    Journal article

    YBX1 integration of oncogenic PI3K/mTOR signalling regulates the fitness of malignant epithelial cells
    DOI: 10.1038/s41467-023-37161-0
  • 2023

    Journal article

    TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
    DOI: 10.1126/scitranslmed.abk1900
  • 2023

    Journal article

    Insights into Cancer Immunotherapies: Recent Breakthroughs, Opportunities, and Challenges
    DOI: 10.3390/cancers15041322

RECENT PROJECTS

  • 2026

    Research grants (other domestic)

    CAR-Adaptors: Guiding CD19-CAR T Cells to Treat Breast Cancers
  • 2026

    Research grants (other domestic)

    Corona-Car T Cells and COVID Vaccine for Cancer Treatment

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224